Sanofi, GSK, Haleon see stock prices dip and dive amid litigation for recalled heartburn drug
Zantac became one of the most well-known drugs on the market after being FDA-approved in 1983 — and now close to four decades later, lawsuits over …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
